Gene · 23607
NIH grants1,872
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,872
Download this page as JSON| Grant | Title | CD2AP papers | Newest fiscal year |
|---|---|---|---|
| R01AG061788 | Multi-Domain Sensory Measures as Biomarkers of Alzheimer's Disease in Preclinical and Prodromal Stages | 1 | 2023 |
| R01AG062588 | Elucidating clinical heterogeneity in early-onset AD via genomics, transcriptomics, and neuroimaging | 1 | 2023 |
| R01AG062634 | Integrative Genomic Approaches for Understanding Sex Differences in Alzheimer's Disease | 1 | 2023 |
| R01AG062695 | Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias | 1 | 2023 |
| R01AG064955 | Genetic Predictors, Transcriptomic Biomarkers, & Neurobiological Signatures of Resilience to Alzheimer's Disease | 1 | 2023 |
| R01AG066206 | Statistical and computational methods for integrative analysis of Alzheimer's Disease genetics | 1 | 2023 |
| R01AG068193 | Cognitive Aging, Alzheimers disease, and Cancer-related Cognitive Decline | 1 | 2023 |
| R01CA233487 | Optimal Decision Making in Radiotherapy Using Panomics Analytics | 1 | 2023 |
| R01DK060635 | Pathogenesis of Diabetic Nephropathy | 1 | 2023 |
| R01DK094004 | Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure | 1 | 2023 |
| R01DK103564 | Role of cytokines and APOL-1 in the pathogenesis of childhood HIV associated nephrology | 1 | 2023 |
| R01ES029916 | Genetic Factors that Influence Arsenic Toxicity | 1 | 2023 |
| R01GM112794 | Maintenance of Adhesion and Barrier Function during Epithelial Cell Shape Changes | 1 | 2023 |
| R01GM134005 | Novel statistical methods and tools to integrate multiple endophenotypes and functional annotation data to study the roles of rare variants in complex human diseases using sequencing data | 1 | 2023 |
| R01HD042601 | Molecular Genetics of BBS | 1 | 2023 |
| R01HL103866 | Gut Flora metabolism of dietary carnitine and cardiovascular disease | 1 | 2023 |
| R01HL148167 | Understanding the Molecular Mechanisms of Fibromuscular Dysplasia | 1 | 2023 |
| R01NS077111 | Modulating selective autophagy to modify Huntington's disease | 1 | 2023 |
| R01NS101483 | Reducing Disparities in Dementia and VCID Outcomes in a Multicultural Rural Population | 1 | 2023 |
| R01NS115139 | Biomarkers of cognitive decline in Parkinson's Disease | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23607/grants?page=21